Edit
Sterling Pharma Solutions
http://www.sterlingpharmasolutions.com/Last activity: 02.03.2022
Active
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. With facilities in Dudley, Northumberland and Deeside, Wales in the UK, as well as Cary, North Carolina and Germantown, Wisconsin in the US our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers.
In addition, our facility in North Carolina offers expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities
In addition, our facility in North Carolina offers expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities
Location: United Kingdom, England, Cramlington
Employees: 501-1000
Phone: +44 191 250 0471
Founded date: 1969
Investors 1
| Date | Name | Website |
| - | GHO Capita... | ghocapital... |
Mentions in press and media 2
| Date | Title | Description |
| 02.03.2022 | Sterling builds up its API capacity with big buy of Novartis campus in Ireland | A massive 111-acre manufacturing site in Ireland owned by Novartis has been acquired by Sterling Pharma Solutions, further bolstering its active pharmaceutical ingredient (API) capacity and providing expanded access for customers. The site ... |
| 08.04.2021 | CDMO Sterling acquires ADC Bio, ramping up capacity for antibody-drug conjugate manufacturing work | Sterling Pharma Solutions has announced the acquisition of ADC Bio, a UK-based company that specializes in antibody drug conjugates. ADC’s Wales manufacturing facility will rebrand to become part of the Sterling ne... |